Cha Z, Qiao Y, Lu Q, Wang Q, Lu X, Zhou H
Front Cell Dev Biol. 2024; 12:1410732.
PMID: 39040041
PMC: 11260720.
DOI: 10.3389/fcell.2024.1410732.
Kumar Podder A, Mohamed M, Seidman R, Tseropoulos G, Polanco J, Lei P
Sci Adv. 2024; 10(28):eadk9918.
PMID: 38996029
PMC: 11244542.
DOI: 10.1126/sciadv.adk9918.
Rust R, Nih L, Liberale L, Yin H, El Amki M, Ong L
Brain. 2024; 147(10):3286-3305.
PMID: 38916992
PMC: 11449145.
DOI: 10.1093/brain/awae204.
Gordon J, Borlongan C
J Cereb Blood Flow Metab. 2024; 44(9):1469-1479.
PMID: 38639015
PMC: 11418600.
DOI: 10.1177/0271678X241227022.
Panos L, Bargiotas P, Arnold M, Hadjigeorgiou G, Panos G
Drug Des Devel Ther. 2024; 18:991-1006.
PMID: 38567255
PMC: 10986404.
DOI: 10.2147/DDDT.S460998.
Recent advances in tissue repair of the blood-brain barrier after stroke.
Qi L, Wang F, Sun X, Li H, Zhang K, Li J
J Tissue Eng. 2024; 15:20417314241226551.
PMID: 38304736
PMC: 10832427.
DOI: 10.1177/20417314241226551.
NCAM mimetic peptide P2 synergizes with bone marrow mesenchymal stem cells in promoting functional recovery after stroke.
Lan X, Liang X, Cao M, Qin H, Chu C, Boltze J
J Cereb Blood Flow Metab. 2024; 44(7):1128-1144.
PMID: 38230663
PMC: 11179606.
DOI: 10.1177/0271678X241226482.
High-frequency repetitive transcranial magnetic stimulation promotes neural stem cell proliferation after ischemic stroke.
Luo J, Feng Y, Hong Z, Yin M, Zheng H, Zhang L
Neural Regen Res. 2023; 19(8):1772-1780.
PMID: 38103244
PMC: 10960276.
DOI: 10.4103/1673-5374.389303.
Preconditioning with interleukin-1 alpha is required for the neuroprotective properties of mesenchymal stem cells after ischemic stroke in mice.
Wong R, Smith C, Allan S, Pinteaux E
J Cereb Blood Flow Metab. 2023; 43(12):2040-2048.
PMID: 37602422
PMC: 10925871.
DOI: 10.1177/0271678X231197109.
Non-human primate models of focal cortical ischemia for neuronal replacement therapy.
Mu J, Hao P, Duan H, Zhao W, Wang Z, Yang Z
J Cereb Blood Flow Metab. 2023; 43(9):1456-1474.
PMID: 37254891
PMC: 10414004.
DOI: 10.1177/0271678X231179544.
Synergistic therapeutic effects of intracerebral transplantation of human modified bone marrow-derived stromal cells (SB623) and voluntary exercise with running wheel in a rat model of ischemic stroke.
Yabuno S, Yasuhara T, Nagase T, Kawauchi S, Sugahara C, Okazaki Y
Stem Cell Res Ther. 2023; 14(1):10.
PMID: 36691091
PMC: 9872315.
DOI: 10.1186/s13287-023-03236-4.
Gap Junction-Mediated Transport of Metabolites Between Stem Cells and Vascular Endothelial Cells.
Ogawa Y, Akamatsu R, Fuchizaki A, Yasui K, Saino O, Tanaka M
Cell Transplant. 2022; 31:9636897221136151.
PMID: 36401520
PMC: 9679345.
DOI: 10.1177/09636897221136151.
Peripheral blood monocytes as a therapeutic target for marrow stromal cells in stroke patients.
Satani N, Parsha K, Davis C, Gee A, Olson S, Aronowski J
Front Neurol. 2022; 13:958579.
PMID: 36277912
PMC: 9580494.
DOI: 10.3389/fneur.2022.958579.
Mesenchymal stem cell aggregation mediated by integrin α4/VCAM-1 after intrathecal transplantation in MCAO rats.
Ran Y, Dong Y, Li Y, Xie J, Zeng S, Liang C
Stem Cell Res Ther. 2022; 13(1):507.
PMID: 36273220
PMC: 9587602.
DOI: 10.1186/s13287-022-03189-0.
Outgrowth Endothelial Cell Conditioned Medium Negates TNF-α-Evoked Cerebral Barrier Damage: A Reverse Translational Research to Explore Mechanisms.
Kadir R, Alwjwaj M, Rakkar K, Othman O, Sprigg N, Bath P
Stem Cell Rev Rep. 2022; 19(2):503-515.
PMID: 36056287
PMC: 9902316.
DOI: 10.1007/s12015-022-10439-4.
Ischemic Brain Stroke and Mesenchymal Stem Cells: An Overview of Molecular Mechanisms and Therapeutic Potential.
Jingli Y, Jing W, Saeed Y
Stem Cells Int. 2022; 2022:5930244.
PMID: 35663353
PMC: 9159823.
DOI: 10.1155/2022/5930244.
Standard toxicity study of clinical-grade allogeneic human bone marrow-derived clonal mesenchymal stromal cells.
Tayebi B, Babaahmadi M, Pakzad M, Hajinasrollah M, Mostafaei F, Jahangiri S
Stem Cell Res Ther. 2022; 13(1):213.
PMID: 35619148
PMC: 9137136.
DOI: 10.1186/s13287-022-02899-9.
Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke.
Zhou L, Zhu H, Bai X, Huang J, Chen Y, Wen J
Stem Cell Res Ther. 2022; 13(1):195.
PMID: 35551643
PMC: 9096773.
DOI: 10.1186/s13287-022-02876-2.
Dental-Pulp Stem Cells as a Therapeutic Strategy for Ischemic Stroke.
Nito C, Suda S, Nitahara-Kasahara Y, Okada T, Kimura K
Biomedicines. 2022; 10(4).
PMID: 35453487
PMC: 9032844.
DOI: 10.3390/biomedicines10040737.
Neuroinflammation, Stem Cells, and Stroke.
Anthony S, Cabantan D, Monsour M, Borlongan C
Stroke. 2022; 53(5):1460-1472.
PMID: 35380050
PMC: 9038685.
DOI: 10.1161/STROKEAHA.121.036948.
